The US Centers for Medicare and Medicaid Services has taken a step toward implementing one of the policies in the Trump Administration’s drug price reduction blueprint by proposing to lower short-term Medicare payments for certain new physician-administered drugs reimbursed under Part B.
The proposal is part of the 2019 Medicare Physician Fee Schedule update, released July 12. It would reduce payments...








